<DOC>
	<DOCNO>NCT00879814</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability investigational meningococcal B rLP2086 vaccine healthy adult .</brief_summary>
	<brief_title>Study Evaluating Safety And Tolerability Of Meningococcal B Rlp2086 Vaccine In Healthy Adults</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis , Meningococcal</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>A subject must meet follow inclusion criterion screen ( visit 1 ) randomization ( visit 2 ) consider enrollment study : Male female subject age 18 40 . Healthy male female subject determine medical history , physical examination , judgment investigator . Male female subject consider biologically capable child must agree commit use reliable method birth control duration study 30 day early discontinuation . A subject still biologically capable child , even use contraceptive sexual partner sterile use contraceptive . In addition subject must meet follow inclusion criterion randomization ( visit 2 ) consider enrollment study . The referred blood urinalysis test ( inclusion criterion 5 ) perform blood urine sample take visit 1 : Female subject childbearing potential negative urine pregnancy test prior study drug administration . Note : criterion apply vaccination visit last study visit . Laboratory blood urinalysis test result within perprotocol normal range . Able contact telephone study period . Note : criterion apply study visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>